Location: Virtual | 10 – 11 a.m. EST
Parenteral drug products are often packaged in one of two forms: an aqueous solution or a dry powder that is dissolved in a solvent prior to administration. While both forms present unique challenges, powder products are difficult to fill in an aseptic environment.
This webinar examines a case study from Evonik, a leading global contract development and manufacturing organization, and how it improved its powder transfer process utilizing innovative technology from STERIS Life Sciences and ChargePoint Technology.
Register for Powder Transfer Webinar
Meet the Presenters
Darren Garvey, Vice President of Sales at ChargePoint Technology, has over 39 years of experience working in product design, project management and sales for various technology companies. He has been with ChargePoint Technology for 13 years, during which time he has helped Customers in the pharmaceutical, biopharmaceutical and chemical industries enhance their containment and aseptic processing procedures.
Caroline Hand, Production Engineer at Evonik, has experience leading cross-departmental teams to support capital project closure, including management of commissioning, qualification and validation activities. She has been with Evonik for over 4 years and specializes in parenteral fill finish and aseptic drug manufacturing and is experienced in technical transfer to support GMP commercialization of new drug products.
Matt Hofacre, Application Project Management Director at STERIS Life Sciences, has over 23 years of experience in the life sciences pharmaceuti/biopharmaceutical production, food and beverage, medical device and laboratory research industries. His team assists STERIS Life Sciences Customers with design applications, project maintenance and technical guidance for integrated Vaporized Hydrogen Peroxide (VHP) systems.